{"id":"https://openalex.org/W7225620581","doi":"https://doi.org/10.3389/fonc.2026.1960236","title":"A TLS-associated immune-activation transcriptomic score is associated with prognosis and the immune landscape in breast cancer","display_name":"A TLS-associated immune-activation transcriptomic score is associated with prognosis and the immune landscape in breast cancer","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225620581","doi":"https://doi.org/10.3389/fonc.2026.1960236"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.1960236","doi":"https://doi.org/10.3389/fonc.2026.1960236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1960236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1960236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1960236/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101009227","display_name":"Hongxiang Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hongxiang Lin","raw_affiliation_strings":["Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126969685","display_name":"Yixin Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yixin Pan","raw_affiliation_strings":["Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030219498","display_name":"Peizhang Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peizhang Liu","raw_affiliation_strings":["Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113345767","display_name":"Junhuan He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junhuan He","raw_affiliation_strings":["Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161329349","display_name":"Jing Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jing Zhang","raw_affiliation_strings":["Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101038838","display_name":"Zhijian Huang","orcid":"https://orcid.org/0009-0007-0403-3116","observed_orcids":["https://orcid.org/0009-0007-0403-3116"]},"institutions":[{"id":"https://openalex.org/I129708740","display_name":"Fujian Medical University","ror":"https://ror.org/050s6ns64","country_code":"CN","type":"education","lineage":["https://openalex.org/I129708740"]},{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I4210148548","display_name":"Fujian Provincial Cancer Hospital","ror":"https://ror.org/058ms9w43","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210148548"]}],"countries":["CN","US"],"is_corresponding":true,"raw_author_name":"Zhijian Huang","raw_affiliation_strings":["Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School","Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital","institution_ids":["https://openalex.org/I129708740","https://openalex.org/I4210148548"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5101038838","https://openalex.org/A5161329349"],"corresponding_institution_ids":["https://openalex.org/I129708740","https://openalex.org/I1316535847","https://openalex.org/I4210148548"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.18960000574588776,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tertiary-lymphoid-structures","display_name":"tertiary lymphoid structures","score":0.9959999918937683},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/tumor-immune-infiltration","display_name":"tumor immune infiltration","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9079999923706055},{"id":"https://openalex.org/keywords/b-cell-infiltration","display_name":"B cell infiltration","score":0.6990000009536743},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9929999709129333},{"id":"https://openalex.org/keywords/t-follicular-helper-cells","display_name":"T follicular helper cells","score":0.9700000286102295},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7160000205039978},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.7554000020027161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7501999735832214},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7160000205039978},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6665999889373779},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6310999989509583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5996999740600586},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4909000098705292},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47510001063346863},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.414900004863739},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3824000060558319},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.37610000371932983},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.35179999470710754},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3508000075817108},{"id":"https://openalex.org/C83546350","wikidata":"https://www.wikidata.org/wiki/Q1139051","display_name":"Regression","level":2,"score":0.3400999903678894},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.28349998593330383},{"id":"https://openalex.org/C57742111","wikidata":"https://www.wikidata.org/wiki/Q7168","display_name":"Histology","level":2,"score":0.26989999413490295},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2651999890804291}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fonc.2026.1960236","doi":"https://doi.org/10.3389/fonc.2026.1960236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1960236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1960236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.1960236","doi":"https://doi.org/10.3389/fonc.2026.1960236","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.1960236","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1960236/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320321878","display_name":"Natural Science Foundation of Fujian Province","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225620581.pdf","grobid_xml":"https://content.openalex.org/works/W7225620581.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W2020627452","https://openalex.org/W2079936875","https://openalex.org/W2260996817","https://openalex.org/W2528849844","https://openalex.org/W2605215962","https://openalex.org/W2771978163","https://openalex.org/W2969718750","https://openalex.org/W2998795792","https://openalex.org/W3000311037","https://openalex.org/W3096066296","https://openalex.org/W3109885192","https://openalex.org/W3128646645","https://openalex.org/W3191177172","https://openalex.org/W4205511851","https://openalex.org/W4214620261","https://openalex.org/W4220874827","https://openalex.org/W4280519874","https://openalex.org/W4288886379","https://openalex.org/W4294216483","https://openalex.org/W4386002140","https://openalex.org/W4388162527","https://openalex.org/W4389042261","https://openalex.org/W4401505664","https://openalex.org/W4403479110"],"related_works":["https://openalex.org/W7148991089","https://openalex.org/W4386002140","https://openalex.org/W4280596065","https://openalex.org/W3207912452","https://openalex.org/W7129407582","https://openalex.org/W4362535343","https://openalex.org/W7154475669","https://openalex.org/W4402307208","https://openalex.org/W4388968422","https://openalex.org/W7160532968"],"abstract_inverted_index":{"Objective":[0],"Tertiary":[1],"lymphoid":[2,7,211],"structures":[3],"(TLS)":[4],"are":[5],"ectopic":[6],"aggregates":[8],"that":[9],"arise":[10],"in":[11,18,36,163,240],"non-lymphoid":[12],"tissues":[13],"during":[14],"chronic":[15],"inflammation":[16],"and":[17,29,33,47,66,90,122,165,167,187,216,237,268],"tumors.":[19],"We":[20],"aimed":[21],"to":[22,73,107],"develop":[23],"a":[24,137,168,210,251,260],"TLS-associated":[25,229],"immune-activation":[26,230],"transcriptomic":[27],"score":[28,80,99,224,231],"evaluate":[30],"its":[31],"prognostic":[32,111],"immune":[34,118,238],"correlates":[35],"breast":[37,243],"cancer.":[38],"Methods":[39],"TCGA-BRCA":[40,164],"was":[41,61,71,81,100,133,196,232],"used":[42,94,134],"as":[43,49,136,250],"the":[44,74,110],"discovery":[45],"cohort":[46],"METABRIC":[48],"an":[50,179,255],"independent":[51],"validation":[52,270],"cohort.":[53],"A":[54,78,205],"published":[55],"39-gene":[56],"cross-tumor":[57],"TLS-related":[58],"candidate":[59],"panel":[60],"screened":[62],"using":[63,104],"Cox":[64,76,105,171],"regression":[65,106],"Kaplan\u2013Meier":[67],"analysis.":[68],"Benjamini\u2013Hochberg":[69,148],"correction":[70,149],"applied":[72],"39":[75],"tests.":[77],"seven-gene":[79,228],"calculated":[82],"by":[83],"single-sample":[84],"gene":[85],"set":[86],"enrichment":[87],"analysis":[88,172],"(ssGSEA),":[89],"cohort-specific":[91],"cutoffs":[92],"were":[93,127],"for":[95],"group-based":[96],"analyses.":[97],"The":[98,141,192,227],"also":[101],"evaluated":[102],"continuously":[103],"assess":[108],"whether":[109],"association":[112,193],"depended":[113],"on":[114],"dichotomization.":[115],"Differential":[116],"expression,":[117],"infiltration,":[119],"genomic":[120],"alterations,":[121],"tumor":[123],"mutational":[124],"burden":[125],"(TMB)":[126],"evaluated.":[128],"Histology":[129],"from":[130],"one":[131],"patient":[132],"only":[135],"qualitative":[138],"illustration.":[139],"Results":[140],"seven":[142],"selected":[143],"genes":[144],"remained":[145],"significant":[146,198],"after":[147],"(false-discovery":[150],"rate":[151],"<":[152],"0.05).":[153],"TLS-high":[154,176],"patients":[155,162],"had":[156],"longer":[157],"overall":[158],"survival":[159,236],"than":[160,259],"TLS-low":[161],"METABRIC,":[166],"supplementary":[169],"continuous-score":[170],"gave":[173],"concordant":[174],"results.":[175],"tumors":[177],"showed":[178,209],"immune-active":[180,256],"profile,":[181],"including":[182],"higher":[183],"B-cell,":[184],"CD8+":[185,217],"T-cell,":[186],"T":[188],"follicular":[189],"helper-cell":[190],"estimates.":[191],"with":[194,213,235],"TMB":[195],"statistically":[197],"but":[199,220],"weak":[200],"(Spearman":[201],"R":[202],"=":[203],"0.11).":[204],"single":[206],"illustrative":[207],"specimen":[208],"aggregate":[212],"CD20+":[214],"B-cell":[215],"T-cell":[218],"areas":[219],"did":[221],"not":[222],"validate":[223],"specificity.":[225],"Conclusion":[226],"reproducibly":[233],"associated":[234],"infiltration":[239],"two":[241],"retrospective":[242],"cancer":[244],"cohorts.":[245],"It":[246],"should":[247],"be":[248],"interpreted":[249],"bulk-transcriptomic":[252],"marker":[253],"of":[254,264],"state":[257],"rather":[258],"histologically":[261],"validated":[262],"measure":[263],"TLS":[265],"abundance.":[266],"Prospective":[267],"spatial":[269],"is":[271],"required":[272],"before":[273],"clinical":[274],"use.":[275]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}